Dysregulation of HIF pathways is implicated in several diseases. In cancer, for instance, HIFs can promote tumor growth and metastasis by enhancing angiogenesis and altering metabolism. Chronic activation of HIFs is also linked to diseases like pulmonary hypertension and chronic kidney disease. Understanding HIF regulation and function can provide insights into potential therapeutic targets for these conditions.
